Stretch current-induced abnormal impulses in CaMKIIδ knockout mouse ventricular myocytes

J Cardiovasc Electrophysiol. 2013 Apr;24(4):457-63. doi: 10.1111/jce.12060. Epub 2012 Dec 21.

Abstract

Background: CaMKII activation is proarrhythmic in heart failure where myocardium is stretched. However, the arrhythmogenic role of CaMKII in stretched ventricle has not been well understood.

Objective: We tested abnormal impulse inducibility by stretch current in myocytes isolated from CaMKIIδ knockout (KO) mouse left ventricle (LV) where CaMKII activity is reduced by ≈ 62%.

Methods and results: Action potentials were recorded by whole-cell patch clamp, and abnormal impulses were induced in LV myocytes by a simulation of stretch-activated channel (SAC) current. SAC activation failed to induce abnormal impulses in wild type (WT) myocytes but steadily produced early after-depolarizations and automaticity in KO myocytes in which an increase in L-type calcium channel (LTCC) current (I(Ca)) and a reduction of sarcoplasmic reticulum Ca(2+) leak and action potential duration (APD) were observed. The abnormal impulses were not suppressed by CaMKII inhibitor AIP whereas a low concentration of nifedipine eliminated abnormal impulses without shortening APD, implicating I(Ca) in promoting stretch-induced abnormal impulses. In addition, APD prolongation by LTCC opener S(-)Bay K 8644 or isoproterenol facilitated abnormal impulse induction in WT ventricular myocytes even in the presence of CaMKII inhibitor AIP, whereas APD prolongation by K(+) channel blocker 4-aminopyridine promoted abnormal impulses in KO myocytes but not in WT myocytes.

Conclusion: I(Ca) activation plays a central role in stretch-induced abnormal impulses and APD prolongation is arrhythmogenic only when I(Ca) is highly activated. At increased I(Ca) activation, CaMKII inhibition cannot suppress abnormal impulse induction.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials
  • Adrenergic beta-Agonists / pharmacology
  • Animals
  • Arrhythmias, Cardiac / enzymology*
  • Arrhythmias, Cardiac / genetics
  • Arrhythmias, Cardiac / physiopathology
  • Calcium / metabolism
  • Calcium Channel Agonists / pharmacology
  • Calcium Channel Blockers / pharmacology
  • Calcium Channels, L-Type / metabolism
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / antagonists & inhibitors
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / deficiency*
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / genetics
  • Enzyme Activation
  • Evoked Potentials
  • Heart Ventricles / drug effects
  • Heart Ventricles / enzymology*
  • Mechanoreceptors / metabolism*
  • Mice
  • Mice, Knockout
  • Myocytes, Cardiac / enzymology*
  • Patch-Clamp Techniques
  • Potassium Channel Blockers / pharmacology
  • Protein Kinase Inhibitors / pharmacology
  • Sarcoplasmic Reticulum / metabolism
  • Time Factors

Substances

  • Adrenergic beta-Agonists
  • Calcium Channel Agonists
  • Calcium Channel Blockers
  • Calcium Channels, L-Type
  • Potassium Channel Blockers
  • Protein Kinase Inhibitors
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • Camk2d protein, mouse
  • Calcium